Ariadna Lafourcade Prada

Dr. Ariadna Lafourcade Prada


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
JKJuliana Camila Fischer Karnopp
Juliana Camila Fischer Karnopp
JJJuliana Jorge
Juliana Jorge
JSJaqueline Rodrigues da Silva
Jaqueline Rodrigues da Silva
DBDiego Boldo
Diego Boldo
KSKristiane Fanti Del Pino Santos
Kristiane Fanti Del Pino Santos
MMMarco Antonio Utrera Martines
Marco Antonio Utrera Martines
This study describes the synthesis and characterization of chlorambucil (CLB)-functionalized mesoporous silica nanoparticles (MSNs) for potential application in cancer therapy. The nanoparticles were designed with a diameter between 20 and 50 nm to optimize cellular uptake and avoid rapid clearance from the bloodstream. The synthesis method involved modifying a previously reported technique to reduce particle size. Successful functionalization with CLB was confirmed through various techniques, including Fourier transform infrared spectroscopy (FTIR) and elemental analysis. The cytotoxicity of the CLB-functionalized nanoparticles (MSN@NH2-CLB) was evaluated against human lung adenocarcinoma cells (A549) and colon carcinoma cells (CT26WT). The results suggest significantly higher cytotoxicity of MSN@NH2-CLB compared to unbound CLB, with improved selectivity towards cancer cells over normal cells. This suggests that MSN@NH2-CLB holds promise as a drug delivery system for targeted cancer therapy.

21 June 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MAMaria Medina De Azevedo
Maria Medina De Azevedo
Francislaine Aparecida dos Reis LíveroFrancislaine Aparecida dos Reis Lívero
Francislaine Aparecida dos Reis Lívero
STSílvia Beatriz Bürger Tinelli
Sílvia Beatriz Bürger Tinelli
JSJacenir Vieira da Silva
Jacenir Vieira da Silva
DADANIELLE AYR TAVARES DE ALMEIDA
DANIELLE AYR TAVARES DE ALMEIDA
AJArquimedes Gasparotto Junior
Arquimedes Gasparotto Junior
Attalea phalerata Martius ex Spreng is a palm tree that is widely distributed in the Central-West region of Brazil. In this study, we investigated whether the oil-loaded nanocapsules of A. phalerata (APON) have acute and long-lasting antihypertensive effects in male spontaneously hypertensive rats (SHR), as well as explored the underlying molecular mechanisms. APON was prepared using the interfacial polymer deposition method. The particle size, polydispersity index, and zeta potential were investigated using dynamic and electrophoretic light scattering. The antihypertensive effects of APON (administered at doses of 1, 3, and 10 mg/kg) were evaluated after acute intraduodenal administration and after 7 days of oral treatment. To investigate the molecular pathways involved, we used pharmacological antagonists and inhibitors that target prostaglandin/cyclic adenosine monophosphate, nitric oxide/cyclic guanosine monophosphate, and potassium channels. Both acute and prolonged administration of APON (at doses of 3 and 10 mg/kg) resulted in a significant reduction in systolic, diastolic, and mean arterial pressure. Prior treatment with a non-selective nitric oxide synthase inhibitor (Nω-nitro-L-arginine methyl ester), guanylyl cyclase inhibitor (methylene blue), or non-selective calcium-sensitive K+ channel blocker (tetraethylammonium) abolished the antihypertensive effects of APON. Our study showed that A. phalerata oil-loaded nanocapsules have a significant antihypertensive effect in SHR after both short-term and long-term (7-day) use. This effect seems to rely on the vascular endothelium function and involves the NO-cGMP-K+ channel pathway. This research suggests a new direction for future studies to definitively prove the therapeutic benefits of APON in treating cardiovascular disease.

24 July 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
APAriadna Lafourcade Prada
Ariadna Lafourcade Prada
JAJesus Rafael Rodriguez Amado
Jesus Rafael Rodriguez Amado
RPRenata Trentin Perdomo
Renata Trentin Perdomo
GIOVANA BICUDO GOMESGIOVANA BICUDO GOMES
GIOVANA BICUDO GOMES
DADanielle Ayr Tavares de Almeida
Danielle Ayr Tavares de Almeida
MMMarco Antonio Utrera Martines
Marco Antonio Utrera Martines
Background: Diabetes and cancer are two of the most life-threatening disorders affecting individuals of all ages worldwide. This study aimed to develop a novel Acrocomia aculeata (bocaiuva) fruit pulp oil-loaded nanoemulsion and evaluate its inhibitory effects on α-glucosidase and pancreatic lipase, as well as its antiglycant activity and cytotoxicity against cancer cells. Additionally, this study assessed the impact of both the oil and the nanoemulsion on blood cells. Methods: The pulp oil was extracted by cold pressing. The oil’s physicochemical properties were determined according to the AOAC and the Brazilian Pharmacopeia. The lipid profile was performed by GC-MS. The nanoemulsion was prepared by the phase inversion method using ultrasonic stirring for particle size reduction and for homogenization. Response Surface Methodology was used for optimizing nanoemulsion preparation. Enzyme inhibition tests were conducted using assay kits. Cytotoxicity in cancer cells was evaluated using the Sulforhodamine B assay. Results: Comprehensive physicochemical and chemical characterization of bocaiuva oil was performed, identifying oleic acid (71.25%) as the main component. The oil contains 23.04% saturated fatty acids, 73.79% monounsaturated acids, and 3.0% polyunsaturated fatty acids. The nanoemulsion (particle size 173.6 nm; zeta potential −14.10 mV) inhibited α-glucosidase (IC50: 43.21 µg/mL) and pancreatic lipase (IC50: 41.99 µg/mL), and revealed a potent antiglycation effect (oxidative IC50: 18.36 µg/mL; non-oxidative pathway IC50: 16.33 µg/mL). The nanoemulsion demonstrated good cytotoxicity and selectivity against prostate cancer cells (IC50: 19.13 µg/mL) and breast cancer cells (IC50: 27.22 µg/mL), without inducing hemolysis, platelet aggregation, or anticoagulant effects. Conclusions: In this study, a comprehensive physical and chemical characterization of bocaiuva fruit pulp oil was conducted for the first time as a preliminary step toward its future standardization as an active ingredient in cosmetic and pharmaceutical formulations. The resulting nanoemulsion represents a novel alternative for managing diabetes and cancer. Although the nanoemulsion exhibited lower cytotoxicity compared to doxorubicin, it remains promising due to its composition of essential fatty acids, phenols, and carotenoids, which offer multiple health benefits. Further studies are needed to validate its efficacy and safety in clinical applications.

4 August 2025 in REVISTA DELOS
Verified
Journal Article
Open access
PDF file
JAJesus Rafael Rodriguez Amado
Jesus Rafael Rodriguez Amado
AMAnnye Vitória Moraes
Annye Vitória Moraes
ALAndréa Roledo Lima
Andréa Roledo Lima
AJArquimedes Gasparotto Junior
Arquimedes Gasparotto Junior
MMMarco Antonio Utrera Martines
Marco Antonio Utrera Martines
APAriadna Lafourcade Prada
Ariadna Lafourcade Prada
Ostrich (Struthio camelus) oil emerges as a valuable source of bioactives with applications in nutraceutical, pharmaceutical, and cosmetic sciences. Despite its unique chemical composition rich in omega fatty acids and fat-soluble vitamins, research on its biological and commercial applications remains still limited. This review explores extraction methods, physicochemical properties, bioactive components, and the utility of this product in cosmetics, functional foods, and pharmaceuticals. It was made a deep review of scientific (Scopes, Dove, Elsevier) and patent sources (USPTO, WIPO, EPO) to explore ostrich oil extraction methods, composition, and uses. The quality of ostrich oils varies depending on the extraction method, diet, and environment. Supercritical fluid extraction produces oil with high purity but a limited yielding, while Low-Temperature rendering balances yield and oxidative stability. The oil has been shown to have antibacterial, wound healing, anti-inflammatory, and antioxidant properties, supporting its use in skincare, and osteoarthritic diseases. Minor bioactive components present in ostrich oil, including tocopherols, sterols, and vitamins A and E enhance their functional profile, making it an ideal candidate for dietary supplements, cosmetics, and pharmaceuticals. Additionally, its high thermal stability supports food applications, such as frying and goods products, where it improves sensory attributes and lipid profiles. Regulatory frameworks vary internationally, with stricter safety assessments in the US and EU compared to emerging markets. Despite its multifaceted benefits, research on ostrich oil remains still limited, necessitating more studies on dietary supplementation, extraction enhancements, and pharmaceutical applications. Optimizing farming practices, refining extraction techniques, and conducting clinical trials will be essential in establishing ostrich oil as a functional ingredient for cosmetics, food, and pharmaceutical applications.